Stock Analysis on Net

AstraZeneca PLC (NYSE:AZN)

$22.49

This company has been moved to the archive! The financial data has not been updated since March 10, 2015.

Dividend Discount Model (DDM)

Microsoft Excel

Paying users area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Intrinsic Stock Value (Valuation Summary)

AstraZeneca PLC, dividends per share (DPS) forecast

US$

Microsoft Excel
Year Value DPSt or Terminal value (TVt) Calculation Present value at
0 DPS01
1 DPS1 = × (1 + )
2 DPS2 = × (1 + )
3 DPS3 = × (1 + )
4 DPS4 = × (1 + )
5 DPS5 = × (1 + )
5 Terminal value (TV5) = × (1 + ) ÷ ()
Intrinsic value of AstraZeneca PLC common stock (per share)
Current share price

Based on: 20-F (reporting date: 2014-12-31).

1 DPS0 = Sum of the last year dividends per share of AstraZeneca PLC common stock. See details »

Disclaimer!
Valuation is based on standard assumptions. There may exist specific factors relevant to stock value and omitted here. In such a case, the real stock value may differ significantly form the estimated. If you want to use the estimated intrinsic stock value in investment decision making process, do so at your own risk.


Required Rate of Return (r)

Microsoft Excel
Assumptions
Rate of return on LT Treasury Composite1 RF
Expected rate of return on market portfolio2 E(RM)
Systematic risk of AstraZeneca PLC common stock βAZN
 
Required rate of return on AstraZeneca PLC common stock3 rAZN

1 Unweighted average of bid yields on all outstanding fixed-coupon U.S. Treasury bonds neither due or callable in less than 10 years (risk-free rate of return proxy).

2 See details »

3 rAZN = RF + βAZN [E(RM) – RF]
= + []
=


Dividend Growth Rate (g)

Dividend growth rate (g) implied by PRAT model

AstraZeneca PLC, PRAT model

Microsoft Excel
Average Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Selected Financial Data (US$ in millions)
Dividends
Profit attributable to owners of the Parent
Revenue
Total assets
Capital and reserves attributable to equity holders of the Company
Financial Ratios
Retention rate1
Profit margin2
Asset turnover3
Financial leverage4
Averages
Retention rate
Profit margin
Asset turnover
Financial leverage
 
Dividend growth rate (g)5

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

2014 Calculations

1 Retention rate = (Profit attributable to owners of the Parent – Dividends) ÷ Profit attributable to owners of the Parent
= () ÷
=

2 Profit margin = 100 × Profit attributable to owners of the Parent ÷ Revenue
= 100 × ÷
=

3 Asset turnover = Revenue ÷ Total assets
= ÷
=

4 Financial leverage = Total assets ÷ Capital and reserves attributable to equity holders of the Company
= ÷
=

5 g = Retention rate × Profit margin × Asset turnover × Financial leverage
= × × ×
=


Dividend growth rate (g) implied by Gordon growth model

g = 100 × (P0 × rD0) ÷ (P0 + D0)
= 100 × ( × ) ÷ ( + )
=

where:
P0 = current price of share of AstraZeneca PLC common stock
D0 = the last year dividends per share of AstraZeneca PLC common stock
r = required rate of return on AstraZeneca PLC common stock


Dividend growth rate (g) forecast

AstraZeneca PLC, H-model

Microsoft Excel
Year Value gt
1 g1
2 g2
3 g3
4 g4
5 and thereafter g5

where:
g1 is implied by PRAT model
g5 is implied by Gordon growth model
g2, g3 and g4 are calculated using linear interpoltion between g1 and g5

Calculations

g2 = g1 + (g5g1) × (2 – 1) ÷ (5 – 1)
= + () × (2 – 1) ÷ (5 – 1)
=

g3 = g1 + (g5g1) × (3 – 1) ÷ (5 – 1)
= + () × (3 – 1) ÷ (5 – 1)
=

g4 = g1 + (g5g1) × (4 – 1) ÷ (5 – 1)
= + () × (4 – 1) ÷ (5 – 1)
=